LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) EBT Growth (5y) (2019 - 2026)

Analysis

LivaNova (LIVN) EBT Growth (5y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.65%
Mar 31, 2026 24.40%
Dec 31, 2025 15.90%
Sep 30, 2025 30.69%
Jun 30, 2025 28.75%
Mar 31, 2025 -120.86%
Dec 31, 2024 18.83%
Sep 30, 2024 15.67%
Jun 30, 2024 21.12%
Mar 31, 2024 -9.77%
Dec 31, 2023 19.52%
Sep 30, 2023 26.03%
Jun 30, 2023 -22.40%
Mar 31, 2023 -15.05%
Dec 31, 2022 -4.12%
Sep 30, 2022 -41.23%
Jun 30, 2022 -21.33%
Mar 31, 2022 -23.23%
Dec 31, 2021 -16.03%
Sep 30, 2021 -31.63%